NPKI vs ECG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

NPKI

47.1
AI Score
VS
NPKI Wins

ECG

39.5
AI Score

Investment Advisor Scores

NPKI

47score
Recommendation
HOLD

ECG

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NPKI ECG Winner
Revenue 156.66M 2.27B ECG
Net Income 22.43M 142.21M ECG
Net Margin 14.3% 6.3% NPKI
Operating Income 30.51M 189.46M ECG
ROE 6.0% 18.4% ECG
ROA 5.0% 6.9% ECG
Total Assets 449.73M 2.06B ECG
Debt/Equity 0.03 0.36 NPKI
Current Ratio 1.61 1.59 NPKI

Relative Price Performance (Last 90 Days)

NPKI 1M: -5.6% · 3M: -10.4% ECG 1M: -8.7% · 3M: -16.4%

Current Technical Phase

NPKI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.2 · Price: $13.68

ECG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 42

RSI (14): 42.5 · Price: $125.96

Fundamentals Snapshot

Metric NPKI ECG
Market Cap
Forward P/E 21.8 21.0
Trailing P/E 30.7 26.1
Revenue (TTM)
Revenue Growth 0.2% 0.3%
Gross Margin 0.4% 0.1%
Operating Margin 0.2% 0.1%
EPS 0.45 4.81
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NPKI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.